Christopher’s Resume

PhD

Carnegie Mellon University (2016)

Founder and President

Quill Science LLC

2023—

• Quill Science is a communications and strategy firm supporting medical PR, biopharma, and life sciences companies through accurate and actionable messaging.

• Expertise in life sciences and medical marketing, medical education, and medical affairs, supporting effective messaging to key stakeholders and promoting thought leadership positioning.

• Science-backed content strategy to capitalize on positioning within market and audience white space and help drive action from target audiences, delivering white papers, blog posts, articles, and more.

Director, Medical Strategy

Neon, an IPG Health Company

2023 — 2024 (contract)

• Excellent domain knowledge and independent research capability across therapeutic areas, acting as the primary medical resource for client teams across therapeutic areas, including rheumatology, ophthalmology, oncology/hematology, neurology, endocrinology, COVID-19, and mast cell diseases.

• Strategic thinking exemplified by providing supportable, fact-driven medical direction for brand strategic and tactical planning for global pharmaceutical clients.

• Keen attention to the commercial market used in newsletters, communications, and brand planning to inform and execute strategic positioning of assets and clinical programs.

Supervisor, Scientific Strategy

Spectrum Science

2021 — 2023

• Demonstrated creative and strategic thinking in crafting corporate and scientific messaging and narrative documents, shaping the communication directions and priorities for large and small biotech and pharmaceutical clients.

• Excellent research capability used in new business pitches, contributing to 6 new client wins and business growth worth over $2 million in new revenue.

• Effective communication and people management skills shown by developing scientific concepts for 3 MOA videos and numerous fact sheets, and working with creative and account teams to bring them to life.

Medical Writer & Strategic Analyst

Freelance

2020 — 2021

• Strong organizational and time management skills demonstrated by completing projects ahead of schedule to successfully meet changing deadlines for 2 boutique medical communications firms.

• Strong adaptability, organizational, and time management skills evidenced by quickly and independently orienting in new therapeutic areas including oncology, cardiovascular disease, immunology, and neurology, resulting in the timely completion of over 10 independent projects.

• Critical eye for data quality enabling effective searches of literature and clinical trials databases, producing 3 comprehensive asset dashboards for a large pharmaceutical company and 1 therapeutic landscape slide deck including commercial and disease state landscape for a biotech startup.

• Excellent domain and market knowledge demonstrated by publishing 5 commissioned technical articles for life sciences reagent company Biotium.

• Relationship builder with growth mindset supported by identifying and promoting client needs, completing freelance contracts on time, and winning repeat clients.

Research Associate

Northwestern University Feinberg School of Medicine

2017 — 2019

• Excellent project and people management skills as evidenced by achieving milestones in multiple projects with a team of scientists, leading to 3 publications and 1 manuscript in preparation.

• Superior time management skills leading to the submission of grant renewals and applications on tight deadlines, recognizing over $900,000 in group funding.

• Strong quantitative and programming skills demonstrated by the development of a novel colocalization algorithm using Python computer vision techniques featured in 1 publication.

• Outstanding critical thinking and attention to detail demonstrated by timely and thorough peer review of 3 manuscripts as a reviewer for top neuroscience journals.

• Excellent creativity demonstrated by elegant experimental designs and generation of new rodent models, resulting in the discovery of a novel epilepsy gene with a developmental critical period.

Research Scientist

Carnegie Mellon University Department of Biological Sciences,
Bruchez Group

2011 — 2019

• With exceptional leadership skills, leveraged the abilities of lab members and productive collaborators to complete projects, producing 2 first author publications and 1 international collaboration

• Excellent verbal and written communication skills leading to 10 presentations at international conferences including 1 as an invited speaker.

• Strong mentorship capability for training colleagues in best practices and techniques, as demonstrated by training 3 successful graduate students, 1 postdoc, and 1 undergraduate student in the laboratory.